These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21840723)

  • 1. The structure-activity relationship of urea derivatives as anti-tuberculosis agents.
    Brown JR; North EJ; Hurdle JG; Morisseau C; Scarborough JS; Sun D; Korduláková J; Scherman MS; Jones V; Grzegorzewicz A; Crew RM; Jackson M; McNeil MR; Lee RE
    Bioorg Med Chem; 2011 Sep; 19(18):5585-95. PubMed ID: 21840723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties.
    North EJ; Scherman MS; Bruhn DF; Scarborough JS; Maddox MM; Jones V; Grzegorzewicz A; Yang L; Hess T; Morisseau C; Jackson M; McNeil MR; Lee RE
    Bioorg Med Chem; 2013 May; 21(9):2587-99. PubMed ID: 23498915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR Selectivity Analysis of 1-Adamantyl-3-Heteroaryl Urea Analogs as Potent Inhibitors of Mycobacterium tuberculosis.
    Wadhwa P; Bagchi S; Sharma A
    Curr Comput Aided Drug Des; 2015; 11(2):164-83. PubMed ID: 26234390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability.
    Scherman MS; North EJ; Jones V; Hess TN; Grzegorzewicz AE; Kasagami T; Kim IH; Merzlikin O; Lenaerts AJ; Lee RE; Jackson M; Morisseau C; McNeil MR
    Bioorg Med Chem; 2012 May; 20(10):3255-62. PubMed ID: 22522007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
    Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
    Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid synthesis of an array of trisubstituted urea-based soluble epoxide hydrolase inhibitors facilitated by a novel solid-phase method.
    Kowalski JA; Swinamer AD; Muegge I; Eldrup AB; Kukulka A; Cywin CL; De Lombaert S
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3703-7. PubMed ID: 20472432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach.
    Ryan A; Polycarpou E; Lack NA; Evangelopoulos D; Sieg C; Halman A; Bhakta S; Eleftheriadou O; McHugh TD; Keany S; Lowe ED; Ballet R; Abuhammad A; Jacobs WR; Ciulli A; Sim E
    Br J Pharmacol; 2017 Jul; 174(14):2209-2224. PubMed ID: 28380256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial Epoxide Hydrolase EphD Is Inhibited by Urea and Thiourea Derivatives.
    Madacki J; Kopál M; Jackson M; Korduláková J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidyl-urea based inhibitors of soluble epoxide hydrolases.
    Morisseau C; Newman JW; Tsai HJ; Baecker PA; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5439-44. PubMed ID: 16908134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Danilov D; Harris TR; Dalinger I; Vatsadze I; Shkineva T; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5514-9. PubMed ID: 26520661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
    Morisseau C; Goodrow MH; Dowdy D; Zheng J; Greene JF; Sanborn JR; Hammock BD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8849-54. PubMed ID: 10430859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MoS
    Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
    ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
    Anandan SK; Gless RD
    Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Lee KS; Shihadih DS; Harris TR; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2014 May; 24(9):2193-7. PubMed ID: 24685540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of dihydroneopterin aldolase from
    Czeczot AM; Muniz MN; Perelló MA; Silva ÉED; Timmers LFSM; Berger A; Gonzalez LC; Arraché Gonçalves G; Moura S; Machado P; Bizarro CV; Basso LA
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2388207. PubMed ID: 39140692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
    Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
    Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives.
    Lopes-Ortiz MA; Panice MR; Borges de Melo E; Ataide Martins JP; Baldin VP; Agostinho Pires CT; Caleffi-Ferracioli KR; Dias Siqueira VL; Bertin de Lima Scodro R; Sarragiotto MH; Cardoso RF
    Eur J Med Chem; 2020 Feb; 187():111935. PubMed ID: 31816556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
    Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
    Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
    Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
    Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.